Pfizer Pricing Increase

Dear Customer, Pfizer, the sole-manufacturer of Depo-Medrol to the marketplace, has increased its prices on Depo-Medrol multiple times over the past year. According to an article by Repertoire dail-enews, the manufacturer is increasing its prices on multi-dose Depo-Medrol again, which will result in an increase to all customers effective on June 25th. Below is an excerpt  … read more

Available Now! 2015-2016 Influenza Vaccines In Stock at Clint Pharmaceuticals

According to the Centers for Disease Control and Prevention (CDC), influenza (flu) causes millions of illnesses, hundreds of thousands of hospitalizations and thousands of deaths every season.  Flu outbreaks can happen as early as October each year. Every year seasonal influenza (flu) viruses are indicated in over 200,000 hospitalizations in the United States.  On average,  … read more

FDA Issues DSCSA Implementation Guidance for Pharmaceutical Dispensers

New regulatory legislation (House bill H.R. 3204), the Drug Quality and Security Act (DQSA), that affects all participants drug supply chain participants (manufacturers, 3PL’s, distributors, pharmacies, and dispensers) was signed into law on November 27, 2013.  The FDA’s goals associated with this legislation are to: enable verification of the legitimacy of the drug product identifier  … read more

Clint Pharmaceuticals Unveils New e-Commerce Website

On June 25, 2015, Clint Pharmaceuticals (CPI) implemented a new e-Commerce system and website.  This site will provide its customers with 24×7 access to Clint’s electronic catalog and online ordering capabilities.  The site is a safe, secure, and convenient way to become a Clint customer and order products when it is most convenient to do  … read more

FDA Enacts New Pharma Supply Chain “Track and Trace” Regulations

On January 1, 2015, the initial elements of the FDA’s new supply chain track-and-trace regulations were enacted.  The new legislation (House bill H.R. 3204, the Drug Quality and Security Act (DQSA) was signed into law on November 27, 2013. This legislation mandates a decade-long roadmap for tracing of pharmaceutical drugs through the supply chain.  It  … read more

CPI Awarded VAWD Accreditation by the National Boards of Pharmacy

Since Clint Pharmaceuticals, Inc. (CPI) was founded in 1987, the company has been committed to maintaining the highest standard of compliance, safety, and service for its thousands of business customers. Clint maintains a policy of only stocking FDA-approved pharmaceutical products and has consistently avoided the use of compound products or other indirectly sourced medical products.  … read more

CPI Joins the Healthcare Distributors and Manufacturers Association (HDMA)

Clint Pharmaceuticals is pleased to have been accepted as a member of the Healthcare Distributors and Manufacturers Association (HDMA) in December 2014.  The HDMA is “A trade association that represents pharmaceutical and related healthcare product distributors throughout the Americas.” HDMA’s mission is to protect patient safety and access to medicines through the safe and efficient  … read more

Jeff Ebel Testifies at FDA Committee on Epidural Corticosteroids

On November 24, 2014, FDA’s Anesthetic and Analgesic Drug Products Advisory Committee conducted a meeting to discuss the efficacy of epidural steroid injections (ESI) administered to reduce inflammation for pain management.  This meeting considered the benefits and risks of ESI corticosteroids, including considerations regarding additional labeling to restrict the usage of ESI’s in pain management.  … read more